Global Preventable Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Preventable Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Preventable Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Adult Preventable Vaccines
1.2.3 Pediatric Preventable Vaccines
1.3 Market Segment by Application
1.3.1 Global Preventable Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Preventable Vaccines Market Size (2017-2028)
2.1.1 Global Preventable Vaccines Revenue (2017-2028)
2.1.2 Global Preventable Vaccines Sales (2017-2028)
2.2 Global Preventable Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Preventable Vaccines Sales by Regions (2017-2022)
2.2.2 Global Preventable Vaccines Revenue by Regions (2017-2022)
2.3 Global Preventable Vaccines Market Size Forecast by Region
2.3.1 Global Preventable Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Preventable Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Preventable Vaccines Regions (Countries) Ranking by Market Size
2.5 Preventable Vaccines Market Dynamics
2.5.1 Preventable Vaccines Market Trends
2.5.2 Preventable Vaccines Market Drivers
2.5.3 Preventable Vaccines Market Challenges
2.5.4 Preventable Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Preventable Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Preventable Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Preventable Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Preventable Vaccines Sales in 2021
3.2 Global Top Manufacturers Preventable Vaccines by Revenue
3.2.1 Global Preventable Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Preventable Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Preventable Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Preventable Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2021)
3.4 Global Preventable Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Preventable Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Preventable Vaccines Market
3.7 Key Manufacturers Preventable Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Preventable Vaccines Market Size by Type
4.1 Global Preventable Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Preventable Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Preventable Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Preventable Vaccines Price by Type (2017-2022)
4.2 Global Preventable Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Preventable Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Preventable Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Preventable Vaccines Price Forecast by Type (2023-2028)
5 Global Preventable Vaccines Market Size by Application
5.1 Global Preventable Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Preventable Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Preventable Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Preventable Vaccines Price by Application (2017-2022)
5.2 Global Preventable Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Preventable Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Preventable Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Preventable Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Preventable Vaccines Sales Breakdown by Company
6.1.1 North America Preventable Vaccines Sales by Company (2017-2022)
6.1.2 North America Preventable Vaccines Revenue by Company (2017-2022)
6.2 North America Preventable Vaccines Market Size by Type
6.2.1 North America Preventable Vaccines Sales by Type (2017-2028)
6.2.2 North America Preventable Vaccines Revenue by Type (2017-2028)
6.3 North America Preventable Vaccines Market Size by Application
6.3.1 North America Preventable Vaccines Sales by Application (2017-2028)
6.3.2 North America Preventable Vaccines Revenue by Application (2017-2028)
6.4 North America Preventable Vaccines Market Size by Country
6.4.1 North America Preventable Vaccines Sales by Country (2017-2028)
6.4.2 North America Preventable Vaccines Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Preventable Vaccines Sales Breakdown by Company
7.1.1 Europe Preventable Vaccines Sales by Company (2017-2022)
7.1.2 Europe Preventable Vaccines Revenue by Company (2017-2022)
7.2 Europe Preventable Vaccines Market Size by Type
7.2.1 Europe Preventable Vaccines Sales by Type (2017-2028)
7.2.2 Europe Preventable Vaccines Revenue by Type (2017-2028)
7.3 Europe Preventable Vaccines Market Size by Application
7.3.1 Europe Preventable Vaccines Sales by Application (2017-2028)
7.3.2 Europe Preventable Vaccines Revenue by Application (2017-2028)
7.4 Europe Preventable Vaccines Market Size by Country
7.4.1 Europe Preventable Vaccines Sales by Country (2017-2028)
7.4.2 Europe Preventable Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Preventable Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Preventable Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Preventable Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Preventable Vaccines Market Size by Type
8.2.1 Asia Pacific Preventable Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Preventable Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Preventable Vaccines Market Size by Application
8.3.1 Asia Pacific Preventable Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Preventable Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Preventable Vaccines Market Size by Region
8.4.1 Asia Pacific Preventable Vaccines Sales by Region
8.4.2 Asia Pacific Preventable Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Preventable Vaccines Sales Breakdown by Company
9.1.1 Latin America Preventable Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Preventable Vaccines Revenue by Company (2017-2022)
9.2 Latin America Preventable Vaccines Market Size by Type
9.2.1 Latin America Preventable Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Preventable Vaccines Revenue by Type (2017-2028)
9.3 Latin America Preventable Vaccines Market Size by Application
9.3.1 Latin America Preventable Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Preventable Vaccines Revenue by Application (2017-2028)
9.4 Latin America Preventable Vaccines Market Size by Country
9.4.1 Latin America Preventable Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Preventable Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
9.4.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Preventable Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Preventable Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Preventable Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Preventable Vaccines Market Size by Type
10.2.1 Middle East and Africa Preventable Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Preventable Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Preventable Vaccines Market Size by Application
10.3.1 Middle East and Africa Preventable Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Preventable Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Preventable Vaccines Market Size by Country
10.4.1 Middle East and Africa Preventable Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Preventable Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Preventable Vaccines Products and Services
11.1.5 GlaxoSmithKline Preventable Vaccines SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Preventable Vaccines Products and Services
11.2.5 Merck Preventable Vaccines SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Novartis Preventable Vaccines Products and Services
11.3.5 Novartis Preventable Vaccines SWOT Analysis
11.3.6 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Pfizer Preventable Vaccines Products and Services
11.4.5 Pfizer Preventable Vaccines SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Sanofi Preventable Vaccines Products and Services
11.5.5 Sanofi Preventable Vaccines SWOT Analysis
11.5.6 Sanofi Recent Developments
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Corporation Information
11.6.2 Takeda Pharmaceutical Overview
11.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Takeda Pharmaceutical Preventable Vaccines Products and Services
11.6.5 Takeda Pharmaceutical Preventable Vaccines SWOT Analysis
11.6.6 Takeda Pharmaceutical Recent Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Overview
11.7.3 Abbott Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Abbott Preventable Vaccines Products and Services
11.7.5 Abbott Preventable Vaccines SWOT Analysis
11.7.6 Abbott Recent Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Roche Preventable Vaccines Products and Services
11.8.5 Roche Preventable Vaccines SWOT Analysis
11.8.6 Roche Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 AstraZeneca Preventable Vaccines Products and Services
11.9.5 AstraZeneca Preventable Vaccines SWOT Analysis
11.9.6 AstraZeneca Recent Developments
11.10 Mitsubishi Tanabe Pharma
11.10.1 Mitsubishi Tanabe Pharma Corporation Information
11.10.2 Mitsubishi Tanabe Pharma Overview
11.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products and Services
11.10.5 Mitsubishi Tanabe Pharma Preventable Vaccines SWOT Analysis
11.10.6 Mitsubishi Tanabe Pharma Recent Developments
11.11 Lupin
11.11.1 Lupin Corporation Information
11.11.2 Lupin Overview
11.11.3 Lupin Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Lupin Preventable Vaccines Products and Services
11.11.5 Lupin Recent Developments
11.12 Serum Institute of India
11.12.1 Serum Institute of India Corporation Information
11.12.2 Serum Institute of India Overview
11.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Serum Institute of India Preventable Vaccines Products and Services
11.12.5 Serum Institute of India Recent Developments
11.13 LG Life Sciences
11.13.1 LG Life Sciences Corporation Information
11.13.2 LG Life Sciences Overview
11.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 LG Life Sciences Preventable Vaccines Products and Services
11.13.5 LG Life Sciences Recent Developments
11.14 S K Chemicals
11.14.1 S K Chemicals Corporation Information
11.14.2 S K Chemicals Overview
11.14.3 S K Chemicals Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 S K Chemicals Preventable Vaccines Products and Services
11.14.5 S K Chemicals Recent Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Corporation Information
11.15.2 Shenzhen Kangtai Biological Products Overview
11.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Products and Services
11.15.5 Shenzhen Kangtai Biological Products Recent Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Corporation Information
11.16.2 Sinovac Biotech Overview
11.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.16.4 Sinovac Biotech Preventable Vaccines Products and Services
11.16.5 Sinovac Biotech Recent Developments
11.17 Janssen Pharmaceuticals
11.17.1 Janssen Pharmaceuticals Corporation Information
11.17.2 Janssen Pharmaceuticals Overview
11.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.17.4 Janssen Pharmaceuticals Preventable Vaccines Products and Services
11.17.5 Janssen Pharmaceuticals Recent Developments
11.18 Crucell
11.18.1 Crucell Corporation Information
11.18.2 Crucell Overview
11.18.3 Crucell Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.18.4 Crucell Preventable Vaccines Products and Services
11.18.5 Crucell Recent Developments
11.19 Bavarian Nordic
11.19.1 Bavarian Nordic Corporation Information
11.19.2 Bavarian Nordic Overview
11.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.19.4 Bavarian Nordic Preventable Vaccines Products and Services
11.19.5 Bavarian Nordic Recent Developments
11.20 Baxter
11.20.1 Baxter Corporation Information
11.20.2 Baxter Overview
11.20.3 Baxter Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.20.4 Baxter Preventable Vaccines Products and Services
11.20.5 Baxter Recent Developments
11.21 Bharat Biotech
11.21.1 Bharat Biotech Corporation Information
11.21.2 Bharat Biotech Overview
11.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.21.4 Bharat Biotech Preventable Vaccines Products and Services
11.21.5 Bharat Biotech Recent Developments
11.22 Dynavax
11.22.1 Dynavax Corporation Information
11.22.2 Dynavax Overview
11.22.3 Dynavax Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.22.4 Dynavax Preventable Vaccines Products and Services
11.22.5 Dynavax Recent Developments
11.23 Bausch Health
11.23.1 Bausch Health Corporation Information
11.23.2 Bausch Health Overview
11.23.3 Bausch Health Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.23.4 Bausch Health Preventable Vaccines Products and Services
11.23.5 Bausch Health Recent Developments
11.24 Protein Sciences
11.24.1 Protein Sciences Corporation Information
11.24.2 Protein Sciences Overview
11.24.3 Protein Sciences Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.24.4 Protein Sciences Preventable Vaccines Products and Services
11.24.5 Protein Sciences Recent Developments
11.25 Panacea Biotec
11.25.1 Panacea Biotec Corporation Information
11.25.2 Panacea Biotec Overview
11.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.25.4 Panacea Biotec Preventable Vaccines Products and Services
11.25.5 Panacea Biotec Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Preventable Vaccines Value Chain Analysis
12.2 Preventable Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Preventable Vaccines Production Mode & Process
12.4 Preventable Vaccines Sales and Marketing
12.4.1 Preventable Vaccines Sales Channels
12.4.2 Preventable Vaccines Distributors
12.5 Preventable Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Preventable Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Adult Preventable Vaccines
Table 3. Major Manufacturers of Pediatric Preventable Vaccines
Table 4. Global Preventable Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Preventable Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Preventable Vaccines Sales by Region (2017-2022) & (K Units)
Table 7. Global Preventable Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Preventable Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Preventable Vaccines Revenue Market Share by Region (2017-2022)
Table 10. Global Preventable Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Preventable Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Preventable Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Preventable Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Preventable Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Preventable Vaccines Market Trends
Table 16. Preventable Vaccines Market Drivers
Table 17. Preventable Vaccines Market Challenges
Table 18. Preventable Vaccines Market Restraints
Table 19. Global Preventable Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Preventable Vaccines Sales Share by Manufacturers (2017-2022)
Table 21. Global Preventable Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Preventable Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 23. Preventable Vaccines Revenue Share by Manufacturers (2017-2022)
Table 24. Global Preventable Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2021)
Table 26. Key Manufacturers Preventable Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Preventable Vaccines Plants/Factories Distribution
Table 28. Key Manufacturers Preventable Vaccines Area Served
Table 29. Date of Key Manufacturers Enter into Preventable Vaccines Market
Table 30. Key Manufacturers Preventable Vaccines Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Preventable Vaccines Sales (K Units) by Type (2017-2022)
Table 33. Global Preventable Vaccines Sales Share by Type (2017-2022)
Table 34. Global Preventable Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Preventable Vaccines Price (K Units) by Type (2017-2022)
Table 36. Global Preventable Vaccines Sales (K Units) by Type (2023-2028)
Table 37. Global Preventable Vaccines Sales Share by Type (2023-2028)
Table 38. Global Preventable Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Preventable Vaccines Revenue Share by Type (2023-2028)
Table 40. Global Preventable Vaccines Price (K Units) by Type (2023-2028)
Table 41. Global Preventable Vaccines Sales (K Units) by Application (2017-2022)
Table 42. Global Preventable Vaccines Sales Share by Application (2017-2022)
Table 43. Global Preventable Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Preventable Vaccines Price (K Units) by Application (2017-2022)
Table 45. Global Preventable Vaccines Sales (K Units) by Application (2023-2028)
Table 46. Global Preventable Vaccines Sales Share by Application (2023-2028)
Table 47. Global Preventable Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Preventable Vaccines Revenue Share by Application (2023-2028)
Table 49. Global Preventable Vaccines Price (K Units) by Application (2023-2028)
Table 50. North America Preventable Vaccines Sales by Company (2017-2022) & (K Units)
Table 51. North America Preventable Vaccines Sales Market Share by Company (2017-2022)
Table 52. North America Preventable Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Preventable Vaccines Revenue Market Share by Company (2017-2022)
Table 54. North America Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. North America Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 56. North America Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 59. North America Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 60. North America Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 63. North America Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 64. North America Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Preventable Vaccines Sales by Company (2017-2022) & (K Units)
Table 67. Europe Preventable Vaccines Sales Market Share by Company (2017-2022)
Table 68. Europe Preventable Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Preventable Vaccines Revenue Market Share by Company (2017-2022)
Table 70. Europe Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 71. Europe Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 72. Europe Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 75. Europe Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 76. Europe Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 79. Europe Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 80. Europe Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Preventable Vaccines Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Preventable Vaccines Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Preventable Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Preventable Vaccines Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Preventable Vaccines Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Preventable Vaccines Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Preventable Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Preventable Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Preventable Vaccines Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Preventable Vaccines Sales Market Share by Company (2017-2022)
Table 100. Latin America Preventable Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Preventable Vaccines Revenue Market Share by Company (2017-2022)
Table 102. Latin America Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Preventable Vaccines Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Preventable Vaccines Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Preventable Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Preventable Vaccines Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Preventable Vaccines Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Preventable Vaccines Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Preventable Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Preventable Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Preventable Vaccines Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Preventable Vaccines Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Preventable Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Preventable Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Preventable Vaccines Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Preventable Vaccines Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Preventable Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Preventable Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Overview
Table 132. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. GlaxoSmithKline Preventable Vaccines Product and Services
Table 134. GlaxoSmithKline Preventable Vaccines SWOT Analysis
Table 135. GlaxoSmithKline Recent Developments
Table 136. Merck Corporation Information
Table 137. Merck Description and Overview
Table 138. Merck Preventable Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. Merck Preventable Vaccines Product and Services
Table 140. Merck Preventable Vaccines SWOT Analysis
Table 141. Merck Recent Developments
Table 142. Novartis Corporation Information
Table 143. Novartis Description and Overview
Table

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs